Neurocloud PET
General Information
Product name
Neurocloud PET
Company
Subspeciality
Neuro
Modality
MR, PET
Disease targeted
Alzheimer's Disease (AD), Parkinson, Dementia, Epilepsy, Encephalitis
Main task
Not specified
Technical Specifications
Population
Patients from 9 to 89 yo
Patient population age
Not specified
Input
18F-FDG 3D iterative reconstruction (mandatory), florbetaben, flutemetamol, flobetapiR, MRI T1 3D (optional)
Input format
DICOM
Output
Color image overlay, ROI analysis, asymmetries, parametric statistical analysis (voxel by voxel), SUVR calculation, positive/negative amyloid result, automatic quantification customizable report
Output format
DICOM, EXCEL, NIFTI, PDF
Integration
Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment
Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)
Trigger for analysis
Etc., Image upload, On demand, Triggered by a user through e.g. a button click
Processing time
1 - 10 minutes
Regulatory Information
CE Certification
Pathway:
MDD
Class:
Class I
Verified by Health AI Register
Other certifications
Not specified
Market Presence
On market since
09-2017
AI Platforms
Alma Health Platform, Deepc
Resellers
Not specified
Countries present
3
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Customizable Plans, Pay-per-use, Subscription
Based on
Customizable Plans, Number of analyses, Number of installations
Evidence & Research
Peer-Reviewed Papers
Source: vendor | First published: Sep 10, 2023 | Last updated: Jul 10, 2025